CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to target shared viral mechanisms, today announced that stockholders elected Patricia...
Hence then, the article about decoy therapeutics stockholders elect patricia gauthier to board of directors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors )
Also on site :
- CSTS Enterprises And Connexus Travel Team Up With Sichuan Airlines Launch Exclusive World Cup-Themed Flights
- Drew Barrymore’s Luxe 3-Shelf Fluted Bookcase Is 'So Stylish' for Modern Homes, and It's Over $75 Off
- Das GIMM-Festival bringt führende Experten der Mikrobiologie nach Lissabon, um über neu auftretende Viren, antimikrobielle Resistenzen und Bioengineering zu diskutieren